Fact CheckerSign in

NCT05531461Recruiting

Cognition and Imaging With Tigertriever

COGNITIVE Study- Cognition and Imaging With Tigertriever

Source: ClinicalTrials.gov · Last updated 9 Oct 2026

Brief summary (registry, in English)

The objective of the COGNITIVE Study is to evaluate whether successful reperfusion with Tigertriever is associated with cognitive benefit.

Status (registry)
Recruiting
Study type
Observational
Enrollment
424 (estimated)
First submitted
4 Sept 2022
Start date
28 Oct 2024
Primary completion date
Nov 2026
Lead sponsor
Rapid Medical
Diseases
Stroke
NCT number
NCT05531461

What you commit to

  • Study type: Observational
  • Planned participants: 424
  • From 28 Oct 2024 to the primary completion date, Nov 2026
  • 6 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Use of any other IA recanalization device prior to the Tigertriever in the target vessel, including aspiration catheter.
  • Prior hemorrhage, stroke, thrombolysis, and/or endovascular therapy in the last 3 months.

Other illness

  • Evidence of acute brain hemorrhage on CT and/or MRI at admission.
  • Pre-stroke diagnosed dementia and/or prescribed cholinesterase inhibitors.
  • Pre-stroke diagnosed and/or currently treated major depression.
  • Pre-stroke learning or intellectual disability.

Other

  • Probable cerebral amyloid angiopathy.
  • Anticipated inability to obtain 6-month follow-up assessments.
    • \-

Who the study is looking for

  • Patients admitted with large vessel occlusion (LVO) and treated with the Tigertriever, as indicated per the approved IFU.
  • Tigertriever was used as the first line treatment in the target vessel.
  • A signed informed consent.
  • Age 18-75 years (inclusive).
  • No known significant pre-stroke disability (pre-stroke mRS 0 or 1).

Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (6)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Corewell Health Research Institute
Coordinator of this site? Confirm its status
Grand RapidsUnited StatesRecruiting
University of California
Coordinator of this site? Confirm its status
Los AngelesUnited StatesRecruiting
Westchester Medical Center
Coordinator of this site? Confirm its status
New YorkUnited StatesRecruiting
University of California Irvine
Coordinator of this site? Confirm its status
OrangeUnited StatesRecruiting
The Hospital of the University of Pennsylvania
Coordinator of this site? Confirm its status
PhiladelphiaUnited StatesRecruiting
Montefiore Medical Center The University Hospital for Albert Einstein College of Medicine
Coordinator of this site? Confirm its status
The BronxUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.